Discuss current evidence from clinical trials and published literature on the efficacy and safety of GLP-1 receptor agonists in patients with SUD
Research has shown it stimulates growth hormone release without significantly affecting cortisol or prolactin, making it one of the most selective GH secretagogues available
For type 1 patients, the most critical safety consideration is hypoglycemia risk when insulin and GLP-1 are combined
How to Prevent Muscle Loss on Ozempic: A Guide for Women Over 40 Video: How to Prevent Muscle Loss on Ozempic Ozempic, Wegovy, Zepbound, and other GLP-1 medications are transforming the weight loss conversationespecially for women over 40
Mehrkens A, Muller AM, Valderrabano V, Scharen S, Vavken P: Tissue engineering approaches to degenerative disc diseasea meta-analysis of controlled animal trials